13 results
pharmacology management inhibitors medications primarycare algorithm comparison diagnosis sglt2 table targets 2018 aace acromegaly agonists classification control curbsiders dmii dpp4
AACE/ACE 2018 Glycemic Control Algorithm #AACE #2018 #Glycemic #Diabetes #DM2 #Control #Medication #Algorithm #Endocrinology #PrimaryCare #Management
AACE/ACE 2018 Glycemic ... #AACE #2018 #Glycemic ... #Diabetes #DM2 ... Medication #Algorithm #Endocrinology
Metformin Pharmacology Summary Mechanisms of Action: • Suppresses gluconeogenesis by the liver • Increases insulin-mediated glucose utilization
Metformin Pharmacology Summary ... agent • Does not cause ... #Pharmacology #Summary ... #DM2 #diabetes ... #endocrinology
Summary and links to five landmark trials of intensive control vs standard therapy in DM2: UKPDS
Summary and links ... standard therapy in DM2 ... VisualAbstract #Endocrinology ... #PrimaryCare #Diabetes ... #DM2 #Type2 #Landmark
Diabetes Medications Summary Table Insulin Lifestyle modifications Metformin Sulfonylureas GLP-1 receptor agonists - ↓ major adverse CV events TZDs DPP-4 inhibitors SGLT2 inhibitors -
Diabetes Medications ... Summary Table ... EricsMedicalLectures/featured #diabetes ... comparison #management #endocrinology ... #dm2
SGLT2 Inhibitors - Pharmacology Summary Mechanisms of Action: Inhibits SGLT2 (sodium/glucose cotransporter 2) in the proximal tubule,
- Pharmacology Summary ... mL/minute/1.73 m2 ... diabetic ketoacidosis ... #DM2 #diabetes ... #endocrinology
Type 2 Diabetes - Screening, Diagnosis and Management Algorithm Lifestyle Modifications (Diet and Exercise) -> Start
Type 2 Diabetes ... relative with DM2 ... Hypertension, Overweight, Abdominal ... • Secondary Causes ... Management #algorithm #DM2
Sulfonylureas - Pharmacology Summary Mechanisms of Action: Binds to the ATP-sensitive potassium channel in pancreatic beta cells,
- Pharmacology Summary ... #Pharmacology #Summary ... #DM2 #diabetes ... #endocrinology
DPP-4 Inhibitors - Pharmacology Summary Mechanisms of Action: Inhibits DPP-4 (dipeptidyl peptidase 4), which normally inactivates GLP-1
- Pharmacology Summary ... not definitively cause ... #Pharmacology #Summary ... #DM2 #diabetes ... #endocrinology
GLP-1 Receptor Agonists - Pharmacology Summary Mechanisms of Action: Stimulate glucose-dependent insulin release from the pancreas (GLP-1
- Pharmacology Summary ... not definitively cause ... #Pharmacology #Summary ... #DM2 #diabetes ... #endocrinology
Diabetes Mellitus Type 2 Inpatient Medication Guide Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
Diabetes Mellitus ... Medication Guide Classes ... insulin in Type 1 Diabetes ... #Mellitus #DM2 ... comparison #table #endocrinology
No results found for "Glycemic+dm2+dm2+pocus orthopedics abdominal causes dm2 summary diabetes endocrinology"
Try removing search terms or sorting by relevance
Or Upload an image for you and others searching for #Glycemic+dm2+dm2+pocus #orthopedics #abdominal #causes #dm2 #summary #diabetes #endocrinology